Source:http://linkedlifedata.com/resource/pubmed/id/18444242
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007600,
umls-concept:C0017262,
umls-concept:C0086418,
umls-concept:C0086661,
umls-concept:C0162832,
umls-concept:C0185117,
umls-concept:C0250455,
umls-concept:C0338106,
umls-concept:C0379710,
umls-concept:C0851285,
umls-concept:C1333572,
umls-concept:C1510779,
umls-concept:C1705723,
umls-concept:C2911684
|
pubmed:issue |
12
|
pubmed:dateCreated |
2008-11-25
|
pubmed:abstractText |
Genetic evidence suggests that caveolin-1, an essential component of membrane caveolae, acts as a tumor promoter in some, and a tumor suppressor in other cancers. The role of caveolin-1 in colon carcinogenesis is controversial. We report here, for the first time, that caveolin-1 is transcriptionally induced in colon cancer cells in response to conditional expression of a full length adenomatous polyposis coli (APC) gene. This induction of caveolin-1 by APC is mediated by both FOXO1a, a member of the Forkhead family of transcription factor, and c-myc. The FOXO1a protein, which is increased by wild-type APC expression, induces caveolin-1 promoter-reporter activity and binds directly to a FKHR consensus binding sequence in the caveolin-1 promoter. The c-myc protein, which is reduced in the presence of wild-type APC, acts to repress caveolin-1 expression by acting at non-E-box containing elements in the caveolin-1 promoter. These data predict that caveolin-1 protein expression would be decreased early in colonic carcinogenesis, which is associated with loss of wild-type APC. Our results would be consistent with the interpretation that caveolin-1 may have tumor suppressing functions during early stages of colon carcinogenesis.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA72008,
http://linkedlifedata.com/resource/pubmed/grant/CA95060,
http://linkedlifedata.com/resource/pubmed/grant/P30 CA023074-209010,
http://linkedlifedata.com/resource/pubmed/grant/P50 CA095060-05,
http://linkedlifedata.com/resource/pubmed/grant/R01 CA123065-01A2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1098-2744
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
947-55
|
pubmed:dateRevised |
2011-5-24
|
pubmed:meshHeading |
pubmed-meshheading:18444242-Adenocarcinoma,
pubmed-meshheading:18444242-Caveolin 1,
pubmed-meshheading:18444242-Cell Line, Tumor,
pubmed-meshheading:18444242-Colonic Neoplasms,
pubmed-meshheading:18444242-Forkhead Transcription Factors,
pubmed-meshheading:18444242-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18444242-Genes, APC,
pubmed-meshheading:18444242-HCT116 Cells,
pubmed-meshheading:18444242-HT29 Cells,
pubmed-meshheading:18444242-Humans,
pubmed-meshheading:18444242-Proto-Oncogene Proteins c-myc
|
pubmed:year |
2008
|
pubmed:articleTitle |
Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc.
|
pubmed:affiliation |
Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|